{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:36:48Z","timestamp":1779194208965,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics Open"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s41669-023-00433-y","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T09:02:14Z","timestamp":1692954134000},"page":"877-886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characteristics and Quality Appraisal of the Economic Evaluations Done in Ethiopia: A Systematic Review"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1758-348X","authenticated-orcid":false,"given":"Bereket Bahiru","family":"Tefera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desalegn Getnet","family":"Demsie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adane","family":"Yehualaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chernet","family":"Tafere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kebede","family":"Feyisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malede Berihun","family":"Yismaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belayneh","family":"Kefale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zewdu","family":"Yilma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"issue":"1","key":"433_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/13696998.2017.1387118","volume":"21","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Feng HM, Qu J, Luo X, Ma WJ, Tian JH. A systematic review of pharmacoeconomic guidelines. J Med Econ. 2018;21(1):85\u201396.","journal-title":"J Med Econ"},{"key":"433_CR2","unstructured":"World Health Organization. Delivering quality health services: a global imperative for universal health coverage. World Health Organization. 2019. https:\/\/www.who.int\/publications\/i\/item\/9789241513906."},{"issue":"2","key":"433_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/20502877.2021.1917101","volume":"27","author":"DG Smithard","year":"2021","unstructured":"Smithard DG, Haslam J. COVID-19 pandemic healthcare resource allocation, age and frailty. New Bioeth. 2021;27(2):127\u201332.","journal-title":"New Bioeth."},{"issue":"2","key":"433_CR4","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.4081\/hls.2014.4572","volume":"2","author":"ND Goldstuck","year":"2014","unstructured":"Goldstuck ND. Healthcare in low-resource settings: the individual perspective. Healthc Low-resour Settings. 2014;2(2):4572.","journal-title":"Healthc Low-resour Settings"},{"issue":"2","key":"433_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40261-018-0730-5","volume":"39","author":"S Farid","year":"2019","unstructured":"Farid S, Elmahdawy M, Baines D. A systematic review on the extent and quality of Pharmacoeconomic publications in Egypt. Clin Drug Investig. 2019;39(2):157\u201368.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"433_CR6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/jgs.16539","volume":"68","author":"TW Farrell","year":"2020","unstructured":"Farrell TW, Francis L, Brown T, et al. Rationing limited healthcare resources in the COVID-19 era and beyond: ethical considerations regarding older adults. Am Geriatr Soc. 2020;68(6):1143\u20139.","journal-title":"Am Geriatr Soc"},{"issue":"8","key":"433_CR7","first-page":"1","volume":"9","author":"BX Tran","year":"2014","unstructured":"Tran BX, Nong VM, Maher RM, Nguyen PK, Luu HN. A systematic review of scope and quality of health economic evaluation studies in Vietnam. PLoS\u00a0One. 2014;9(8):1\u201312.","journal-title":"PLoS\u00a0One"},{"issue":"6","key":"433_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.vhri.2015.11.005","volume":"9","author":"A Dang","year":"2016","unstructured":"Dang A, Likhar N, Alok U. Importance of economic evaluation in health care: an Indian perspective. Value Heal Reg Issues. 2016;9(6):78\u201383.","journal-title":"Value Heal Reg Issues."},{"issue":"13","key":"433_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph19137862","volume":"19","author":"AI Alzarea","year":"2022","unstructured":"Alzarea AI, Khan YH, Alanazi AS, Butt MH, Almalki ZS, Alahmari AK, et al. Barriers and facilitators of pharmacoeconomic studies: a review of evidence from the middle eastern countries. Int J Environ Res Public Health. 2022;19(13):1\u201318.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"433_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/14737167.2018.1479254","volume":"18","author":"I Eljilany","year":"2018","unstructured":"Eljilany I, El-Dahiyat F, Curley LE, Babar ZUD. Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries. Expert Rev Pharmacoeconomics Outcomes Res. 2018;18(4):403\u201314.","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res"},{"issue":"1","key":"433_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18549\/PharmPract.2021.1.2302","volume":"19","author":"FS Tonin","year":"2021","unstructured":"Tonin FS, Aznar-Lou I, Pontinha VM, Pontarolo R, Fernandez-Llimos F. Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions. Pharm Pract (Granada). 2021;19(1):1\u201310.","journal-title":"Pharm Pract (Granada)."},{"key":"433_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.vhri.2017.07.007","volume":"15","author":"P Pandey","year":"2018","unstructured":"Pandey P, Pandey RD, Shah V. Evaluation of quality of pharmacoeconomic studies in Asia-Pacific Region and identification of influencing variables. Value Heal Reg Issues. 2018;15:70\u20135.","journal-title":"Value Heal Reg Issues."},{"key":"433_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.npls.2015.07.001","volume":"1","author":"DA Marshall","year":"2015","unstructured":"Marshall DA, Donald F, Lacny S, Reid K, Bryant-Lukosius D, Carter N, et al. Assessing the quality of economic evaluations of clinical nurse specialists and nurse practitioners: a systematic review of cost-effectiveness. NursingPlus Open. 2015;1:11\u20137.","journal-title":"NursingPlus Open."},{"issue":"1","key":"433_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/s-0033-1341594","volume":"4","author":"N Henrikson","year":"2013","unstructured":"Henrikson N, Skelly A. Economic studies part 2: evaluating the quality. Evid Based Spine Care J. 2013;4(1):2\u20135.","journal-title":"Evid Based Spine Care J."},{"issue":"4","key":"433_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1524-4733.2007.00175.x","volume":"10","author":"T Hoomans","year":"2007","unstructured":"Hoomans T, Evers SMAA, Ament AJHA, H\u00fcbben MWA, Van Der Weijden T, Grimshaw JM, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Heal. 2007;10(4):305\u201316.","journal-title":"Value Heal."},{"issue":"23","key":"433_CR16","first-page":"4","volume":"20","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, De B-G, Briggs AH. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Med. 2022;20(23):4\u201311.","journal-title":"BMC Med"},{"issue":"1","key":"433_CR17","first-page":"53","volume":"9","author":"JJ Ofman","year":"2003","unstructured":"Ofman JJ, Sullivan SD, Neumann PJ, Chiou CF, Henning JM, Wade SW, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm. 2003;9(1):53\u201361.","journal-title":"J Manag Care Pharm"},{"issue":"12","key":"433_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2020-047515","volume":"11","author":"GB Gebretekle","year":"2021","unstructured":"Gebretekle GB, Mariam DH, Mac S, Abebe W, Alemayehu T, Degu WA, et al. Cost-utility analysis of antimicrobial stewardship programme at a tertiary teaching hospital in Ethiopia. BMJ Open. 2021;11(12):1\u201310.","journal-title":"BMJ Open"},{"issue":"4","key":"433_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s41669-021-00275-6","volume":"5","author":"YB Belay","year":"2021","unstructured":"Belay YB, Ali EE, Chung KY, Gebretekle GB, Sander B. Cost-utility analysis of Dolutegravir-versus Efavirenz-based regimens as a first-line treatment in adult HIV\/AIDS patients in Ethiopia. PharmacoEconomics Open. 2021;5(4):655\u201364.","journal-title":"PharmacoEconomics Open"},{"issue":"4","key":"433_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/QAI.0000000000000064","volume":"65","author":"B Johns","year":"2014","unstructured":"Johns B, Asfaw E, Wong W, Bekele A, Minior T, Kebede A, et al. Assessing the costs and effects of antiretroviral therapy task shifting from physicians to other health professionals in Ethiopia. J Acquir Immune Defic Syndr. 2014;65(4):140\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"433_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-020-01328-8","volume":"20","author":"M Olsen","year":"2021","unstructured":"Olsen M, Norheim OF, Memirie ST. Reducing regional health inequality: a sub-national distributional cost-effectiveness analysis of the community-based treatment of childhood pneumonia in Ethiopia. Int J Equity Health. 2021;20(1):1\u201310.","journal-title":"Int J Equity Health"},{"key":"433_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.socscimed.2015.06.018","volume":"139","author":"J Driessen","year":"2015","unstructured":"Driessen J, Olson ZD, Jamison DT. Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: an extended cost-effectiveness analysis. Soc Sci Med. 2015;139:115\u201322.","journal-title":"Soc Sci Med"},{"issue":"1","key":"433_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12962-020-00231-x","volume":"18","author":"A Yigezu","year":"2020","unstructured":"Yigezu A, Alemayehu S, Hamusse SD, Ergeta GT, Hailemariam D, Hailu A. Cost-effectiveness of facility-based, stand-alone and mobile-based voluntary counseling and testing for HIV in Addis Ababa, Ethiopia. Cost Eff Resour Alloc. 2020;18(1):1\u201312.","journal-title":"Cost Eff Resour Alloc."},{"issue":"1","key":"433_CR24","first-page":"1","volume":"2","author":"T Shimels","year":"2019","unstructured":"Shimels T, Bilal AI. Hemodialysis or transplantation for Ethiopia: a cost-utility analysis. Ann Adv Biomed Sci. 2019;2(1):1\u201310.","journal-title":"Ann Adv Biomed Sci."},{"issue":"318","key":"433_CR25","first-page":"1","volume":"17","author":"A Tesfaye","year":"2017","unstructured":"Tesfaye A, Fiseha D, Assefa D, Klinkenberg E, Balanco S, Langley I. Modeling the patient and health system impacts of alternative xpert\u00ae MTB\/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia. BMC Infect Dis. 2017;17(318):1\u20139.","journal-title":"BMC Infect Dis"},{"key":"433_CR26","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/heapol\/czv093","volume":"32","author":"KB Strand","year":"2016","unstructured":"Strand KB, Chisholm D, Fekadu A, Johansson KA. Scaling-up essential neuropsychiatric services in Ethiopia: a cost-effectiveness analysis. Health Policy Plan. 2016;32:504\u201313.","journal-title":"Health Policy Plan"},{"issue":"1078","key":"433_CR27","first-page":"1","volume":"19","author":"TT Kebede","year":"2019","unstructured":"Kebede TT, Svensson M, Addissie A, Trollfors B, Andersson R. Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation. BMC Public Health. 2019;19(1078):1\u201312.","journal-title":"BMC Public Health"},{"key":"433_CR28","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2147\/CEOR.S327868","volume":"13","author":"MT Derseh","year":"2021","unstructured":"Derseh MT, Solomon K, Tamene W, Beneberu W, Yayehrad AT, et al. A cost-effectiveness analysis of rivaroxaban compared to warfarin for Deep Vein Thrombosis (DVT) treatment in Ethiopia. Clin Outcomes Res. 2021;13:821\u201334.","journal-title":"Clin Outcomes Res"},{"key":"433_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.socscimed.2021.114076","volume":"281","author":"MR Enden","year":"2021","unstructured":"Enden MR, Tolla MT, Norheim OF. Providing universal access to modern contraceptive methods: an extended cost-effectiveness analysis of meeting the demand for modern contraception in Ethiopia. Soc Sci Med. 2021;281:1\u201310.","journal-title":"Soc Sci Med"},{"issue":"1","key":"433_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12962-020-00255-3","volume":"19","author":"GT Eregata","year":"2021","unstructured":"Eregata GT, Hailu A, Stenberg K, Johansson KA, Norheim OF, Bertram MY. Generalised cost-effectiveness analysis of 159 health interventions for the Ethiopian essential health service package. Cost Eff Resour Alloc. 2021;19(1):1\u201313.","journal-title":"Cost Eff Resour Alloc."},{"key":"433_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/heapol\/czx054","volume":"32","author":"B Mathewos","year":"2017","unstructured":"Mathewos B, Owen H, Sitrin D, Cousens S, Degefie T, Wall S, et al. Community-Based Interventions for Newborns in Ethiopia (COMBINE): cost-effectiveness analysis. Health Policy Plan. 2017;32:21\u201332.","journal-title":"Health Policy Plan"},{"issue":"4","key":"433_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/heapol\/czz034","volume":"34","author":"ST Memirie","year":"2019","unstructured":"Memirie ST, Tolla MT, Desalegn D, Hailemariam M, Norheim OF, Verguet S, et al. A cost-effectiveness analysis of maternal and neonatal health interventions in Ethiopia. Health Policy Plan. 2019;34(4):289\u201397.","journal-title":"Health Policy Plan"},{"issue":"2","key":"433_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0246207","volume":"16","author":"LF Assebe","year":"2021","unstructured":"Assebe LF, Belete WN, Alemayehu S, Asfaw E, Godana KT, Alemayehu YK, et al. Economic evaluation of Health Extension Program packages in Ethiopia. PLoS ONE. 2021;16(2):1\u201316.","journal-title":"PLoS ONE"},{"issue":"1","key":"433_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12962-018-0164-1","volume":"16","author":"A Hailu","year":"2018","unstructured":"Hailu A, Lindtj\u00f8rn B, Deressa W, Gari T, Loha E, Robberstad B. Cost-effectiveness of a combined intervention of long-lasting insecticidal nets and indoor residual spraying compared with each intervention alone for malaria prevention in Ethiopia. Cost Eff Resour Alloc. 2018;16(1):1\u201317.","journal-title":"Cost Eff Resour Alloc."},{"issue":"1","key":"433_CR35","first-page":"1","volume":"6","author":"M Bekele","year":"2021","unstructured":"Bekele M, Norheim OF, Hailu A. Cost-effectiveness of Saxagliptin compared with Glibenclamide as a second-line therapy added to metformin for type 2 diabetes Mellitus in Ethiopia. MDM Policy Pract. 2021;6(1):1\u201312.","journal-title":"MDM Policy Pract."},{"key":"433_CR36","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.2180719","author":"EA Zegeya","year":"2012","unstructured":"Zegeya EA, Tushune K, Abdosh B, Chrispim PPM. Cost effectiveness analysis of PMTCT service delivery modalities in Addis Ababa (using decision models). SSRN Electron J. 2012. https:\/\/doi.org\/10.2139\/ssrn.2180719.","journal-title":"SSRN Electron J"},{"issue":"3","key":"433_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4314\/ejhd.v16i3.9794","volume":"16","author":"A Zergaw","year":"2002","unstructured":"Zergaw A, Mariam DH, Ali A. Cost-effectiveness analysis of health care interventions in Meskanena Mareko Wereda, Ethiopia. Ethiop J Health Dev. 2002;16(3):267\u201376.","journal-title":"Ethiop J Health Dev."},{"key":"433_CR38","first-page":"1","volume":"15","author":"S Alemayehu","year":"2020","unstructured":"Alemayehu S, Yigezu A, Hailemariam D, Hailu A. Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia. PLoS\u00a0One. 2020;15:1\u201313.","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"433_CR39","first-page":"49","volume":"6","author":"S Toba","year":"2008","unstructured":"Toba S, Tomasini M, Yang YH. Supply chain management in hospital: a case study. Calif J Oper Manag. 2008;6(1):49\u201355.","journal-title":"Calif J Oper Manag."},{"issue":"1","key":"433_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1586\/14737167.1.1.1","volume":"1","author":"JA Mauskopf","year":"2001","unstructured":"Mauskopf JA. Why study pharmacoeconomics? Expert Rev Pharmacoeconomics Outcomes Res. 2001;1(1):1\u20133.","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res"},{"issue":"2","key":"433_CR41","first-page":"1","volume":"16","author":"C Min","year":"2021","unstructured":"Min C, Xue M, Haotian F, Jialian L, Lingli Z. An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics. PLoS\u00a0One. 2021;16(2):1\u201313.","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"433_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40258-016-0280-z","volume":"15","author":"EA Zegeye","year":"2017","unstructured":"Zegeye EA, Mbonigaba J, Kaye SB, Wilkinson T. Economic evaluation in Ethiopian healthcare sector decision making: perception, practice, and barriers. Appl Heal Econ Heal Policy. 2017;15(1):33\u201343.","journal-title":"Appl Heal Econ Heal Policy."},{"issue":"1","key":"433_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.vhri.2014.02.010","volume":"3","author":"S Jiang","year":"2014","unstructured":"Jiang S, Ma X, Desai P, Yang L, Rascati K. A systematic review on the extent and quality of pharmacoeconomic publications for China. Value Heal Reg Issues. 2014;3(1):79\u201386.","journal-title":"Value Heal Reg Issues."},{"issue":"1","key":"433_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-7547-9-12","volume":"9","author":"ME Hoque","year":"2011","unstructured":"Hoque ME, Khan JAM, Hossain SSA, Gazi R, Rashid HA, Koehlmoos TP, et al. A systematic review of economic evaluations of health and health-related interventions in Bangladesh. Cost Eff Resour Alloc. 2011;9(1):12.","journal-title":"Cost Eff Resour Alloc."},{"issue":"3","key":"433_CR45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.curtheres.2008.06.005","volume":"69","author":"P Gavaza","year":"2008","unstructured":"Gavaza P, Rascati K, Brown C, Lawson K, Mann T. The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: a review. Curr Ther Res - Clin Exp. 2008;69(3):268\u201385.","journal-title":"Curr Ther Res - Clin Exp."},{"issue":"41","key":"433_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000005114","volume":"95","author":"H Ma","year":"2016","unstructured":"Ma H, Jian W, Xu T, He Y, Rizzo JA, Fang H. Quality of pharmacoeconomic research in China: a systematic review. Medicine. 2016;95(41):1\u20138.","journal-title":"Medicine"}],"container-title":["PharmacoEconomics - Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-023-00433-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41669-023-00433-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-023-00433-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T09:23:02Z","timestamp":1702545782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41669-023-00433-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1007\/s41669-023-00433-y","relation":{},"ISSN":["2509-4262","2509-4254"],"issn-type":[{"value":"2509-4262","type":"print"},{"value":"2509-4254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"assertion":[{"value":"23 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"This article contains all data generated or analyzed during this study, and anyone requiring clarification can contact the corresponding author.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"There was no funder for this study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"BBT conceived and designed the study. BBT, DGD, AY, CT, KF, MBY, BK, and ZY contributed to the collection and assembly of the data, data analysis, interpretation, and manuscript preparation. All authors commented on the manuscript drafts and read and approved the final version.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' Contributions"}}]}}